Stock Chart
OGN
Type: SELL growth_1yr
Strike: $8
Premium: $0.90
Expiry: Jan 15, 2027
Target: $6
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About OGN - Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
Key Statistics
More OGN Analysis
This OGN stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track OGN's price movements with trendlines, gamma walls, and key support/resistance levels.